TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX) today announced that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York.
ANDOVER, Mass., Aug. 28, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a fireside chat at the upcoming Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York. The fireside chat will take place on Monday, September 11, 2023, at 8:40 a.m. Eastern Time. Event: Morgan Stanley 21st Annual Global Healthcare Conference A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. About TransMedics Group, Inc. Investor Contact:
SOURCE TransMedics Group, Inc. |
||
Company Codes: NASDAQ-NMS:TMDX |